Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email